No abstract available
MeSH terms
-
ADAM Proteins / genetics
-
ADAM Proteins / metabolism
-
ADAMTS13 Protein
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Atypical Hemolytic Uremic Syndrome
-
Biomarkers / metabolism
-
Blood Platelets / drug effects
-
Blood Platelets / pathology
-
Complement Activation / drug effects
-
Complement Inactivating Agents / therapeutic use*
-
Complement System Proteins / genetics*
-
Complement System Proteins / immunology
-
Diagnosis, Differential
-
Disease Management
-
Hemolytic-Uremic Syndrome / complications
-
Hemolytic-Uremic Syndrome / diagnosis
-
Hemolytic-Uremic Syndrome / genetics
-
Hemolytic-Uremic Syndrome / therapy*
-
Humans
-
Mutation
-
Plasma Exchange
-
Platelet Count
-
Purpura, Thrombocytopenic / diagnosis
-
Purpura, Thrombocytopenic / genetics
-
Purpura, Thrombocytopenic / therapy*
-
Renal Insufficiency / etiology
Substances
-
Antibodies, Monoclonal, Humanized
-
Biomarkers
-
Complement Inactivating Agents
-
Complement System Proteins
-
eculizumab
-
ADAM Proteins
-
ADAMTS13 Protein
-
ADAMTS13 protein, human